| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mariana J Kaplan | |
| P2860 | cites work | Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis | Q24801010 |
| Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 | ||
| Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis | Q24816784 | ||
| Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis | Q28168900 | ||
| Cardiovascular risk factors in women with and without rheumatoid arthritis | Q28171426 | ||
| Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction | Q28211707 | ||
| MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction | Q28581447 | ||
| Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis | Q31091902 | ||
| Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 | ||
| Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis | Q33687843 | ||
| Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. | Q33908100 | ||
| Total cholesterol and LDL levels decrease before rheumatoid arthritis | Q33931317 | ||
| Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells | Q33967700 | ||
| Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 | ||
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis | Q34401259 | ||
| Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? | Q34601733 | ||
| Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study | Q34624148 | ||
| Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Rheumatoid arthritis in women: still associated with an increased mortality. | Q34962868 | ||
| Accelerated atherogenesis in autoimmune rheumatic diseases | Q35172082 | ||
| Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis | Q35547305 | ||
| Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 | ||
| Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity | Q35553196 | ||
| Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 | ||
| Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s | Q35554980 | ||
| CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients | Q47438401 | ||
| Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
| Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease | Q48009889 | ||
| Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 | ||
| Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 | ||
| Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. | Q50881711 | ||
| Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. | Q50925165 | ||
| Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. | Q50969877 | ||
| Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. | Q51761535 | ||
| Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. | Q52595013 | ||
| Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. | Q54389817 | ||
| A tale of two diseases: atherosclerosis and rheumatoid arthritis. | Q54448410 | ||
| Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis. | Q54524130 | ||
| Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis | Q57232003 | ||
| Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis | Q57387086 | ||
| Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis | Q57540217 | ||
| The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 | ||
| Tumor necrosis factor receptor type II (exon 6) and interleukin-6 (−174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from | Q57819629 | ||
| Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS) | Q58071481 | ||
| Modulation of CD4 + CD28 null T Lymphocytes by Tumor Necrosis Factor-α Blockade in Patients With Unstable Angina | Q58230246 | ||
| Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study | Q60298067 | ||
| Atherosclerosis in Rheumatoid Arthritis Versus Diabetes | Q60594020 | ||
| Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis | Q61628540 | ||
| Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis | Q61711491 | ||
| Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis | Q63184843 | ||
| Cause of death in rheumatoid arthritis | Q71349315 | ||
| Cardiovascular mortality in women with rheumatoid arthritis | Q72057364 | ||
| Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset | Q73292550 | ||
| Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis | Q73378860 | ||
| Methotrexate causes apoptosis in postmitotic endothelial cells | Q73572177 | ||
| The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis | Q73613525 | ||
| Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects | Q73628316 | ||
| Total mortality is increased in rheumatoid arthritis. A 17-year prospective study | Q73860051 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Long-term morbidity, mortality, and economics of rheumatoid arthritis | Q77406814 | ||
| Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years | Q78794833 | ||
| Acceleration of atherosclerosis during the course of rheumatoid arthritis | Q79348208 | ||
| Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease | Q79354392 | ||
| Role of insulin resistance in increased frequency of atherosclerosis detected by carotid ultrasonography in rheumatoid arthritis | Q79402376 | ||
| Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 | ||
| Independent association of increased trunk fat with increased arterial stiffening in postmenopausal patients with rheumatoid arthritis | Q79784944 | ||
| Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients | Q79808209 | ||
| Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis | Q80124167 | ||
| Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis | Q80182570 | ||
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 | ||
| Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis | Q80234116 | ||
| Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis | Q80442338 | ||
| Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study | Q80791227 | ||
| Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? | Q80800883 | ||
| Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis | Q80843926 | ||
| Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis | Q81070646 | ||
| Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis | Q81252239 | ||
| Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
| Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis | Q81431847 | ||
| Prediction of mortality in rheumatoid arthritis based on disease activity markers | Q81463187 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit | Q81795815 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy | Q82734935 | ||
| Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes | Q84201343 | ||
| Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate | Q84587942 | ||
| The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice | Q84738724 | ||
| Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
| No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. | Q42635206 | ||
| Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis | Q43049221 | ||
| Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study. | Q43241272 | ||
| Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
| Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. | Q43616578 | ||
| The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis | Q43927214 | ||
| Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis | Q44177928 | ||
| Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis | Q44187483 | ||
| Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis | Q44391179 | ||
| Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis | Q44453472 | ||
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 | ||
| Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation | Q45004490 | ||
| Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol | Q45110323 | ||
| Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis | Q45129989 | ||
| Effect of glucocorticoids on the arteries in rheumatoid arthritis | Q45184227 | ||
| Simvastatin improves endothelial function in patients with rheumatoid arthritis | Q45244385 | ||
| Cardiovascular outcomes in male veterans with rheumatoid arthritis. | Q45331961 | ||
| IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. | Q45968562 | ||
| Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis. | Q45989311 | ||
| Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients. | Q45998671 | ||
| Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis | Q46075758 | ||
| Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. | Q46111865 | ||
| Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis | Q46222728 | ||
| Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study | Q46481473 | ||
| Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis | Q46505203 | ||
| Arterial stiffness in chronic inflammatory diseases | Q46505839 | ||
| Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. | Q46632190 | ||
| Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes | Q46697243 | ||
| Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. | Q46787385 | ||
| Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. | Q46852341 | ||
| Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody | Q47368581 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 | ||
| Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells | Q35636813 | ||
| Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome | Q35636932 | ||
| Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis | Q35637252 | ||
| Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis | Q35638288 | ||
| Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 | ||
| Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis | Q35669374 | ||
| Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy | Q35676074 | ||
| The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men | Q36025658 | ||
| Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis | Q36030664 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis | Q36183213 | ||
| Effect of drugs on homocysteine concentrations | Q36208943 | ||
| Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation | Q36465464 | ||
| Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists | Q36742762 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Effect of rheumatoid factor on mortality and coronary heart disease | Q36843049 | ||
| Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis | Q36955395 | ||
| Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages | Q37008144 | ||
| Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction | Q37060522 | ||
| The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. | Q37074034 | ||
| Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors | Q37292191 | ||
| Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study | Q37350896 | ||
| Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis | Q37377439 | ||
| The widening mortality gap between rheumatoid arthritis patients and the general population | Q38459919 | ||
| Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 | ||
| Serum oxidized low-density lipoproteins in rheumatoid arthritis | Q38518891 | ||
| Is atherosclerosis a complication of long-term corticosteroid treatment? | Q39732969 | ||
| Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis | Q39959053 | ||
| Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking | Q40037298 | ||
| Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
| Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis | Q40497949 | ||
| Expansion of unusual CD4+ T cells in severe rheumatoid arthritis | Q41496871 | ||
| Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis | Q41951968 | ||
| Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis | Q42165744 | ||
| HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis | Q42610707 | ||
| P433 | issue | 2 | |
| P921 | main subject | circulatory system | Q11068 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 405-426 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Rheumatic Diseases Clinics of North America | Q7320483 |
| P1476 | title | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | |
| P478 | volume | 36 |
| Q92576552 | Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients |
| Q34344584 | Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis |
| Q27004493 | Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity |
| Q36438919 | Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives |
| Q55413719 | Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. |
| Q38098110 | Biventricular thrombus and associated myocardial infarction in a rheumatoid arthritis patient: a case report and literature review |
| Q36154527 | Body composition in patients with rheumatoid arthritis is not different than healthy subjects |
| Q57472323 | Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction |
| Q26738461 | Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach |
| Q36795979 | Cardiovascular risk factor management in patients with RA compared to matched non-RA patients |
| Q37055056 | Cardiovascular risk score in Rheumatoid Arthritis |
| Q39020908 | Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis |
| Q92652431 | Coronary Artery Aneurysms: Analysis of Comorbidities from the National Inpatient Sample |
| Q38486424 | Developing a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients |
| Q41005889 | Effect of phenolic glycolipids from Mycobacterium kansasii on proinflammatory cytokine release. A structure-activity relationship study |
| Q49282700 | Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial |
| Q35622648 | Evaluation of serum magnesium, lipid profile and various biochemical parameters as risk factors of cardiovascular diseases in patients with rheumatoid arthritis |
| Q37675607 | Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection |
| Q52680357 | From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. |
| Q92589114 | Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review |
| Q34119124 | High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis |
| Q64911996 | Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. |
| Q92708651 | Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration |
| Q37689920 | Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study. |
| Q52583114 | Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure. |
| Q46654494 | Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes |
| Q34343906 | Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus |
| Q88945515 | Microvascular endothelial dysfunction in rheumatoid arthritis |
| Q38549528 | Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective. |
| Q41174889 | Pericardial mass in a patient with rheumatoid arthritis |
| Q38766355 | Reincarnated medicines: using out-dated drugs for novel indications |
| Q36843132 | Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation |
| Q37691220 | Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study |
| Q51245791 | Role of Diet in Influencing Rheumatoid Arthritis Disease Activity. |
| Q33848290 | The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study. |
| Q58204340 | The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan |
| Q36027291 | Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. |
| Q38703393 | miRNA-Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis |
Search more.